A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan

Genetic Vaccines and Therapy

Volumn 10, Issue , 2012, Pages

  Idrees, Sobia ^a   Ashfaq, Usman A ^a  

^a GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

Author keywords

Dengue virus; Diagnosis; Medicinal plants; NS3 protease; Prevalence

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANDROGRAPHIS PANICULATA EXTRACT; ANTIVIRUS AGENT; CARICA PAPAYA EXTRACT; CORE PROTEIN; CYMBOPOGAN CITRATE EXTRACT; ENVELOPE PROTEIN; HEAT SHOCK PROTEIN 70; IBUPROFEN; INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MEMBRANE PROTEIN; MOMORDICA CHARANTIA EXTRACT; NONSTEROID ANTIINFLAMMATORY AGENT; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; OCIMUM SANCTUM EXTRACT; PARACETAMOL; PELARGONIUM SIDOIDES EXTRACT; PLANT EXTRACT; STAPHYLOCOCCUS PROTEIN A; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTHRALGIA; BED NET; BLEEDING TENDENCY; CRYSTAL STRUCTURE; DENGUE; DENGUE VIRUS; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; FLAVIVIRUS; HUMAN; JAPANESE ENCEPHALITIS; LABORATORY DIAGNOSIS; LEMON; LIFE CYCLE; NUCLEAR LOCALIZATION SIGNAL; NUCLEIC ACID AMPLIFICATION; ORAL REHYDRATION THERAPY; PAKISTAN; PAPAYA; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; RNA REPLICATION; SEROTYPE; SIGNAL TRANSDUCTION; VIRUS DETECTION; VIRUS INHIBITION; WEST NILE FLAVIVIRUS;

DENGUE VIRUS;

EID: 84867846632     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-10-6     Document Type: Review

References (94)

1. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010, 8:S7-S16. 10.1038/nrmicro2460, 21079655.
2. Halstead SB. Dengue. Lancet 2007, 370:1644-1655. 10.1016/S0140-6736(07)61687-0, 17993365.
3. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11:480-496. 88892, 9665979.
4. WHO Dengue and severe dengue. WHO Media centre 2012, Fact sheet N°117 http://www.who.int/mediacentre/factsheets/fs117/en/, WHO.
5. Hotta S. Experimental studies on dengue. I. Isolation, identification and modification of the virus. J Infect Dis 1952, 90:1-9. 10.1093/infdis/90.1.1, 14888958.
6. Beatty ME, Stone A, Fitzsimons DW, Hanna JN, Lam SK, Vong S, Guzman MG, Mendez-Galvan JF, Halstead SB, Letson GW, et al. Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis 2010, 4:e890. 10.1371/journal.pntd.0000890, 2982842, 21103381.
7. Fatima Z, Idrees M, Bajwa MA, Tahir Z, Ullah O, Zia MQ, Hussain A, Akram M, Khubaib B, Afzal S, et al. Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC Microbiol 2011, 11:200. 10.1186/1471-2180-11-200, 3180347, 21906394.
8. Ross TM. Dengue virus. Clin Lab Med 2010, 30:149-160. 10.1016/j.cll.2009.10.007, 20513545.
9. Wang E, Ni H, Xu R, Barrett AD, Watowich SJ, Gubler DJ, Weaver SC. Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol 2000, 74:3227-3234. 10.1128/JVI.74.7.3227-3234.2000, 111823, 10708439.
10. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002, 2:33-42. 10.1016/S1473-3099(01)00171-2, 11892494.
11. WHO Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control 1997, World Health Organization, Geneva, 2, WHO.
12. Jahan F. Dengue Fever (DF) in Pakistan. Asia Pac Fam Med 2011, 10:1. 10.1186/1447-056X-10-1, 3050821, 21349169.
13. Hidari KI, Suzuki T. Dengue virus receptor. Trop Med Health 2011, 39:37-43. 10.2149/tmh.2011-S03, 3317600, 22500135.
14. Filomatori CV, Lodeiro MF, Alvarez DE, Samsa MM, Pietrasanta L, Gamarnik AV. A 5' RNA element promotes dengue virus RNA synthesis on a circular genome. Genes Dev 2006, 20:2238-2249. 10.1101/gad.1444206, 1553207, 16882970.
15. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Ennis FA. High levels of interferon alpha in the sera of children with dengue virus infection. AmJTrop Med Hyg 1993, 48:222-229.
16. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 1991, 88:1473-1480. 10.1172/JCI115457, 295652, 1939640.
17. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 2003, 100:14333-14338. 10.1073/pnas.2335168100, 283592, 14612562.
18. Umareddy I, Pluquet O, Wang QY, Vasudevan SG, Chevet E, Gu F. Dengue virus serotype infection specifies the activation of the unfolded protein response. Virol J 2007, 4:91. 10.1186/1743-422X-4-91, 2045667, 17888185.
19. Shu PY, Huang JH. Current advances in dengue diagnosis. Clin Diagn Lab Immunol 2004, 11:642-650. 440621, 15242935.
20. Ma L, Jones CT, Groesch TD, Kuhn RJ, Post CB. Solution structure of dengue virus capsid protein reveals another fold. Proc Natl Acad Sci U S A 2004, 101:3414-3419. 10.1073/pnas.0305892101, 373476, 14993605.
21. Bulich R, Aaskov JG. Nuclear localization of dengue 2 virus core protein detected with monoclonal antibodies. J Gen Virol 1992, 73(Pt 11):2999-3003.
22. Wang SH, Syu WJ, Huang KJ, Lei HY, Yao CW, King CC, Hu ST. Intracellular localization and determination of a nuclear localization signal of the core protein of dengue virus. J Gen Virol 2002, 83:3093-3102.
23. Cardosa MJ, Wang SM, Sum MS, Tio PH. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol 2002, 2:9. 10.1186/1471-2180-2-9, 113253, 12019028.
24. Murray J, Aaskov J, Wright P. Processing of the dengue virus type 2 proteins prM and C-prM. J Gen Virol 1993, 74:175-182. 10.1099/0022-1317-74-2-175, 8429301.
25. Wang S, He R, Anderson R. PrM- and cell-binding domains of the dengue virus E protein. J Virol 1999, 73:2547-2551. 104503, 9971841.
26. Marks RM, Lu H, Sundaresan R, Toida T, Suzuki A, Imanari T, Hernaiz MJ, Linhardt RJ. Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors. J Med Chem 2001, 44:2178-2187. 10.1021/jm000412i, 11405655.
27. Mondotte JA, Lozach PY, Amara A, Gamarnik AV. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. J Virol 2007, 81:7136-7148. 10.1128/JVI.00116-07, 1933273, 17459925.
28. Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427:313-319. 10.1038/nature02165, 14737159.
29. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss2 EG, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2001, 108:717-725.
30. Modis Y, Ogata S, Clements D, Harrison SC. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 2003, 100:6986-6991. 10.1073/pnas.0832193100, 165817, 12759475.
31. Jacobs MG, Robinson PJ, Bletchly C, Mackenzie JM, Young PR. Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J 2000, 14:1603-1610. 10.1096/fj.14.11.1603, 10928995.
32. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002, 40:376-381. 10.1128/JCM.40.02.376-381.2002, 153354, 11825945.
33. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002, 186:1165-1168. 10.1086/343813, 12355369.
34. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, Jairungsri A, Kanlaya R, Tangthawornchaikul N, Puttikhunt C, et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 2006, 193:1078-1088. 10.1086/500949, 16544248.
35. Liu WJ, Chen HB, Wang XJ, Huang H, Khromykh AA. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol 2004, 78:12225-12235. 10.1128/JVI.78.22.12225-12235.2004, 525072, 15507609.
36. Falgout B, Chanock R, Lai CJ. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J Virol 1989, 63:1852-1860. 250595, 2522997.
37. Mackenzie JM, Khromykh AA, Jones MK, Westaway EG. Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology 1998, 245:203-215. 10.1006/viro.1998.9156, 9636360.
38. Falgout B, Pethel M, Zhang YM, Lai CJ. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol 1991, 65:2467-2475. 240601, 2016768.
39. Wang WK, Sung TL, Lee CN, Lin TY, King CC. Sequence diversity of the capsid gene and the nonstructural gene NS2B of dengue-3 virus in vivo. Virology 2002, 303:181-191. 10.1006/viro.2002.1635, 12482670.
40. Falgout B, Miller RH, Lai CJ. Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J Virol 1993, 67:2034-2042. 240272, 8383225.
41. Luo D, Xu T, Hunke C, Gruber G, Vasudevan SG, Lescar J. Crystal structure of the NS3 protease-helicase from dengue virus. J Virol 2008, 82:173-183. 10.1128/JVI.01788-07, 2224403, 17942558.
42. Matusan AE, Pryor MJ, Davidson AD, Wright PJ. Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication. J Virol 2001, 75:9633-9643. 10.1128/JVI.75.20.9633-9643.2001, 114534, 11559795.
43. Teo KF, Wright PJ. Internal proteolysis of the NS3 protein specified by dengue virus 2. J Gen Virol 1997, 78(Pt 2):337-341.
44. Zeng L, Kurane I, Okamoto Y, Ennis FA, Brinton MA. Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones. J Virol 1996, 70:3108-3117. 190173, 8627790.
45. Kapoor M, Zhang L, Ramachandra M, Kusukawa J, Ebner KE, Padmanabhan R. Association between NS3 and NS5 Proteins of Dengue Virus Type 2 in the Putative RNA Replicase Is Linked to Differential Phosphorylation of NS5. J Biol Chem 1995, 270:19100-19106. 10.1074/jbc.270.32.19100, 7642575.
46. Chow VT, Yong RY, Ngoh BL, Chan YC. Automated type specific ELISA probe detection of amplified NS3 gene products of dengue viruses. J Clin Pathol 1997, 50:346-349. 10.1136/jcp.50.4.346, 499889, 9215155.
47. Ganesh VK, Muller N, Judge K, Luan CH, Padmanabhan R, Murthy KH. Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases. Bioorg Med Chem 2005, 13:257-264. 10.1016/j.bmc.2004.09.036, 15582469.
48. Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, Yin Z, Keller TH, Vasudevan SG, Hommel U. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 2006, 13:372-373. 10.1038/nsmb1073, 16532006.
49. Xu T, Sampath A, Chao A, Wen D, Nanao M, Chene P, Vasudevan SG, Lescar J. Structure of the Dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A. J Virol 2005, 79:10278-10288. 10.1128/JVI.79.16.10278-10288.2005, 1182654, 16051821.
50. Miller S, Kastner S, Krijnse-Locker J, Buhler S, Bartenschlager R. The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J Biol Chem 2007, 282:8873-8882. 10.1074/jbc.M609919200, 17276984.
51. Preugschat F, Strauss JH. Processing of nonstructural proteins NS4A and NS4B of dengue 2 virus in vitro and in vivo. Virology 1991, 185:689-697. 10.1016/0042-6822(91)90540-R, 1683727.
52. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, Lipkin WI, Garcia-Sastre A. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 2005, 79:8004-8013. 10.1128/JVI.79.13.8004-8013.2005, 1143737, 15956546.
53. Ackermann M, Padmanabhan R. De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase. J Biol Chem 2001, 276:39926-39937. 10.1074/jbc.M104248200, 11546770.
54. Hanley KA, Lee JJ, Blaney JE, Murphy BR, Whitehead SS. Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes. J Virol 2002, 76:525-531. 10.1128/JVI.76.2.525-531.2002, 136841, 11752143.
55. Johansson M, Brooks AJ, Jans DA, Vasudevan SG. A small region of the dengue virus-encoded RNA-dependent RNA polymerase, NS5, confers interaction with both the nuclear transport receptor importin-beta and the viral helicase, NS3. J Gen Virol 2001, 82:735-745.
56. Egloff MP, Benarroch D, Selisko B, Romette JL, Canard B. An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J 2002, 21:2757-2768. 10.1093/emboj/21.11.2757, 125380, 12032088.
57. Khan E, Hasan R, Mehraj V, Nasir A, Siddiqui J, Hewson R. Co-circulations of two genotypes of dengue virus in 2006 out-break of dengue hemorrhagic fever in Karachi, Pakistan. J Clin Virol 2008, 43:176-179. 10.1016/j.jcv.2008.06.003, 18639489.
58. Hayes CG, Baqar S, Ahmed T, Chowdhry MA, Reisen WK. West Nile virus in Pakistan. 1. Sero-epidemiological studies in Punjab Province. Trans R Soc Trop Med Hyg 1982, 76:431-436. 10.1016/0035-9203(82)90130-4, 6926759.
59. Cobelens FG, Groen J, Osterhaus AD, Leentvaar-Kuipers A, Wertheim-van Dillen PM, Kager PA. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health 2002, 7:331-338. 10.1046/j.1365-3156.2002.00864.x, 11952949.
60. Chan YC, Salahuddin NI, Khan J, Tan HC, Seah CL, Li J, Chow VT. Dengue haemorrhagic fever outbreak in Karachi, Pakistan, 1994. Trans R Soc Trop Med Hyg 1995, 89:619-620. 10.1016/0035-9203(95)90412-3, 8594672.
61. Chong CF, Ngoh BL, Tan HC, Yap EH, Singh M, Chan L, Chan YC. A shortened dengue IgM capture ELISA using simultaneous incubation of antigen and peroxidase-labeled monoclonal antibody. Clin Diagn Virol 1994, 1:335-341. 10.1016/0928-0197(94)90063-9, 15566747.
62. Paul RE, Patel AY, Mirza S, Fisher-Hoch SP, Luby SP. Expansion of epidemic dengue viral infections to Pakistan. Int J Infect Dis 1998, 2:197-201. 10.1016/S1201-9712(98)90052-2, 9763501.
63. Humayoun MA, Waseem T, Jawa AA, Hashmi MS, Akram J. Multiple dengue serotypes and high frequency of dengue hemorrhagic fever at two tertiary care hospitals in Lahore during the 2008 dengue virus outbreak in Punjab, Pakistan. Int J Infect Dis 2010, 14(Suppl 3):e54-e59.
64. Akram DS, Igarashi A, Takasu T. Dengue virus infection among children with undifferentiated fever in Karachi. Indian J Pediatr 1998, 65:735-740. 10.1007/BF02731055, 10773930.
65. Jamil B, Hasan R, Zafar A, Bewley K, Chamberlain J, Mioulet V, Rowlands M, Hewson R. Dengue virus serotype 3, Karachi, Pakistan. Emerg Infect Dis 2007, 13:182-183. 10.3201/eid1301.060376, 2725812, 17370547.
66. Khan E, Siddiqui J, Shakoor S, Mehraj V, Jamil B, Hasan R. Dengue outbreak in Karachi, Pakistan, 2006: experience at a tertiary care center. Trans R Soc Trop Med Hyg 2007, 101:1114-1119. 10.1016/j.trstmh.2007.06.016, 17706259.
67. Dash PK, Parida MM, Saxena P, Abhyankar A, Singh CP, Tewari KN, Jana AM, Sekhar K, Rao PV. Reemergence of dengue virus type-3 (subtype-III) in India: implications for increased incidence of DHF & DSS. Virol J 2006, 3:55. 10.1186/1743-422X-3-55, 1559593, 16824209.
68. Siddiqui FJ, Haider SR, Bhutta ZA. Endemic dengue fever: a seldom recognized hazard for Pakistani children. J Infect Dev Ctries 2009, 3:306-312.
69. ARYNews 2010, http://www.arynews.tv/english/newsdetail.asp?nid=38981, ARYNews.
70. Mahmood N, Rana MY, Qureshi Z, Mujtaba G, Shaukat U. Prevalence and molecular characterization of dengue viruses serotypes in 2010 epidemic. Am J Med Sci 2010, 343:61-64.
71. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. AmJTrop Med Hyg 1988, 38:172-180.
72. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, Vaughn DW, Ennis FA. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002, 156:40-51. 10.1093/aje/kwf005, 12076887.
73. Singh K, Lale A, Eong OE, Chiu L, Chow V, Tambyah P, Koay E. A prospective clinical study on the use of reverse transcription-polymerase chain reaction for the early diagnosis of Dengue fever. J Mol Diagn 2006, 8:613-616. 10.2353/jmoldx.2006.060019, 1876169, 17065431.
74. Laue T, Emmerich P, Schmitz H. Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. J Clin Microbiol 1999, 37:2543-2547. 85278, 10405398.
75. Kuno G, Cropp CB, Wong-Lee J, Gubler DJ. Evaluation of an IgM immunoblot kit for dengue diagnosis. AmJTrop Med Hyg 1998, 59:757-762.
76. Dussart P, Labeau B, Lagathu G, Louis P, Nunes MR, Rodrigues SG, Storck-Herrmann C, Cesaire R, Morvan J, Flamand M, Baril L. Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin Vaccine Immunol 2006, 13:1185-1189. 10.1128/CVI.00229-06, 1656554, 16988003.
77. Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, Chin C, Lin TH, Huang JH. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diagn Lab Immunol 2003, 10:622-630. 164246, 12853395.
78. Datta S, Wattal C. Dengue NS1 antigen detection: a useful tool in early diagnosis of dengue virus infection. Indian J Med Microbiol 2010, 28:107-110. 10.4103/0255-0857.62484, 20404453.
79. Butt N, Abbassi A, Munir SM, Ahmad SM, Sheikh QH. Haematological and biochemical indicators for the early diagnosis of dengue viral infection. J Coll Physicians Surg Pak 2008, 18:282-285.
80. Yap G, Sil BK, Ng L-C. Use of saliva for early dengue diagnosis. PLoS Negl Trop Dis 2010, 5(5):e1046.
81. Rattue P. Dengue Test Using Flu Diagnostic Equipment Approved, USA. Medical News Today 2012, http://www.medicalnewstoday.com/articles/246967.php.
82. Selisko B, Guillemot J-C, Alvarez K, Canard B. Opportunities in the development of ANTI-dengue drugs 2006, Geneva.
83. Tang LI, Ling AP, Koh RY, Chye SM, Voon KG. Screening of anti-dengue activity in methanolic extracts of medicinal plants. BMC Complement Altern Med 2012, 12:3. 10.1186/1472-6882-12-3, 3269354, 22244370.
84. Huet J, Looze Y, Bartik K, Raussens V, Wintjens R, Boussard P. Structural characterization of the papaya cysteine proteinases at low pH. Biochem Biophys Res Commun 2006, 341:620-626. 10.1016/j.bbrc.2005.12.210, 16434027.
85. Ahmad N, Fazal H, Ayaz M, Abbasi BH, Mohammad I, Fazal L. Dengue fever treatment with Carica papaya leaves extracts. Asian Pac J Trop Biomed 2011, 330:333.
86. Parida MM, Upadhyay C, Pandya G, Jana AM. Inhibitory potential of neem (Azadirachta indica Juss) leaves on dengue virus type-2 replication. J Ethnopharmacol 2002, 79:273-278. 10.1016/S0378-8741(01)00395-6, 11801392.
87. Talarico LB, Damonte EB. Interference in dengue virus adsorption and uncoating by carrageenans. Virology 2007, 363:473-485. 10.1016/j.virol.2007.01.043, 17337028.
88. Rahman NA, , Muliawan S, Rashid NN, Muhamad M, Yusof R. Hadinur Studies on quercus lusitanica extracts on DENV-2 replication. Dengue Bull 2006, 30:260-269. Hadinur.
89. Tong XK, Qiu H, Zhang X, Shi LP, Wang GF, Ji FH, Ding HY, Tang W, Ding K, Zuo JP. WSS45, a sulfated alpha-D-glucan, strongly interferes with Dengue 2 virus infection in vitro. Acta Pharmacol Sin 2010, 31:585-592. 10.1038/aps.2010.29, 20418898.
90. McDowell M, Gonzales SR, Kumarapperuma SC, Jeselnik M, Arterburn JB, Hanley KA. A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1, 2, 4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro. Antiviral Res 2010, 87:78-80. 10.1016/j.antiviral.2010.04.007, 2892036, 20416341.
91. Kiat TS, Pippen R, Yusof R, Ibrahim H, Khalid N, Rahman NA. Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. Bioorg Med Chem Lett 2006, 16:3337-3340. 10.1016/j.bmcl.2005.12.075, 16621533.
92. Allard PM, Dau ET, Eydoux C, Guillemot JC, Dumontet V, Poullain C, Canard B, Gueritte F, Litaudon M. Alkylated flavanones from the bark of Cryptocarya chartacea as dengue virus NS5 polymerase inhibitors. J Nat Prod 2011, 74:2446-2453. 10.1021/np200715v, 22050318.
93. Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J 2011, 8:560. 10.1186/1743-422X-8-560, 3271998, 22201648.
94. Zandi K, Teoh B-T, Sam S-S, Wong P-F, Mustafa MR, AbuBakar S. In vitro antiviral activity of Fisetin, Rutin and Naringenin against Dengue virus type-2. J Med Plants Res 2011, 5:5534-5539.